Bivin & Associates’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$25K Buy
467
+120
+35% +$6.97K 0.03% 109
2022
Q1
$20K Hold
347
0.02% 145
2021
Q4
$16K Buy
+347
New +$15.8K 0.01% 154

Other funds holding CTVA

Bivin & Associates's CTVA Position: Q2 2022 in Review

Bivin & Associates increased its Corteva (CTVA) stake by 35% in Q2 2022, buying an estimated $6.97K and bringing the position to 467 shares worth $25K. The position accounts for 0.03% of the portfolio, ranked #109.

Bivin & Associates first reported a position in CTVA in Q4 2021 and has held it in 3 quarters since. 1,191 funds tracked by Wall St. Rank hold CTVA as of Q2 2022.

  • Bivin & Associates held 467 shares of Corteva worth $25K as of Q2 2022.
  • Bivin & Associates bought 120 Corteva shares in Q2 2022, an estimated $6.97K.
  • Corteva made up 0.03% of Bivin & Associates's portfolio in Q2 2022, its #109 holding.
  • Bivin & Associates first reported a position in Corteva in Q4 2021 and has held it in 3 quarters since.
  • 1,191 funds tracked by Wall St. Rank held Corteva as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.